A study using cultured splenic ProE and bone marrow cells obtained from mice infected with the anemia-inducing strain of Friend leukemia virus (FVA) suggests that later erythropoietic developmental stages may resolve better when stained with antibodies against CD44 (Chen et al. 2009). The gene discussed is CD44; the disease is anemia.